TL;DR
- Idea: Decentralized funding and liquidity protocol enabling global communities to curate, fund, and govern biotech DAOs through tokenized scientific IP.
- Catalyst: Rapid growth in DeSci sector, trending as top searched on CoinGecko, recent V2 launch and AI hackathon winners driving ecosystem engagement.
- Risks: Regulatory uncertainty in biotech and blockchain, potential volatility from token unlocks, competition from other launchpads and need for broad ecosystem adoption.
- Score: 7.00/ 10
Coin
- Name/ Ticker: Bio Protocol (BIO)
- Segment: DeSci
- Status: active
- Price: $0.204400
Key Metrics
- Market Cap: $408 515 979
- FDV: $677 970 000
- Circulating Supply: 1 671 788 864
- Total Supply: 3 320 000 000
Sources
Technology
- USP: First mover in Decentralized Science (DeSci) providing funding, liquidity, and governance for biotech DAOs.
- Core Technology: Ethereum and Solana smart contracts powering fixed-price launchpad, protocol-owned liquidity engine with secondary market fee model, vote-escrow staking (veBIO) and BioXP reputation system.
Roadmap
- 2024-12-24: Binance Launchpool Farming Start
- 2025-01-03: Token Generation Event and Multi-chain Listing
- 2025-05-28: Phased Vesting Schedule Begins for Team Tokens
- 2025-08-03: Launch of Bio Protocol V2 Phase with Linear Vesting
Team & Investors
Team
- Founder & Tokenomics Lead β Paul Kohlhaas: Co-founder of VitaDAO and Molecule; expert in scientific IP tokenization and on-chain funding models
- Co-Founder & Science Lead β James Sinka: Built R&D and community engagement for decentralized science platforms; background in biotech research
- Legal Counsel β Jose Pinto: Experienced crypto and biotech regulatory advisor
- Product Lead β Leonard Boltz: Led product development for Web3 applications and DeFi launchpads
- Co-Founder & Product Manager β Clemens Ortlepp: Former product manager at Molecule; expertise in product strategy
- Head of Growth β Nate Hindman: Specialist in community growth and marketing for blockchain projects
- Technical Lead β Elliott Brunet: Blockchain software engineer with DeFi protocol experience
Investors
- Pre-Seed Round β pre-seed β’ $0.90M
- Seed Round β seed β’ $1.40M
- Genesis Auction Round 1 β genesis-1 β’ $6.20M
- Genesis Auction Round 2 β genesis-2 β’ $18.20M
- Genesis Auction Round 2.5 β genesis-2.5 β’ $3.50M
- Binance Labs β strategic
Total funding: $30.20M
Tokenomics
- Utility: Governance, staking for veBIO, earning BioXP for launch allocations, funding BioDAOs and providing protocol liquidity.
- Vesting: Team tokens vest over six years with a one-year cliff followed by linear unlock.
Pros & Cons
Strengths
- First-mover in DeSci funding infrastructure
- Strong backing from Binance Labs and leading VCs
- Innovative liquidity engine with secondary market fees
- Multi-chain deployment on Ethereum, Solana and Base
- Active community with BioXP and hackathon engagement
- Experienced team from VitaDAO and Molecule
- Transparent governance via veBIO staking
Weaknesses
- Regulatory risks in biotech and securities
- Potential volatility from token unlock events
- Competition from other launchpad protocols
- Complexity of DeSci narrative for mainstream adoption
- Reliance on continued community growth and engagement
- Exposure to Ethereum gas fees for key operations
Price Scenarios (target: 2026-02-26)
- Bear: $0.100000 β 50% decline from current price to nearest support level
- Base: $0.350000 β Projected based on 1% capture of DeSci market cap growth
- Bull: $1.000000 β Value assuming broad adoption and FDV doubling through ecosystem expansion
How to Buy & Store
CEX
- Binance
- Coinbase
- KuCoin
- Gate.io
- OKX
DEX
- Uniswap
- SushiSwap
- Balancer
- Raydium
- PancakeSwap
Storage
- MetaMask
- Trust Wallet
- Ledger
- Trezor
- Coinbase Wallet
Verdict
Bio Protocol offers a unique and promising infrastructure for decentralized science funding with solid investor backing and innovative tokenomics, but faces execution and regulatory challenges. Recommended as a medium-term hold.
Official Links
Source: Coin Research (internal)
Comments (0)